ACS Chemical Neuroscience Associate Editor Anne Andrews received a 2017 National Institutes of Health Director’s Transformative Research Award. The award, which is part of the NIH’s High-Risk, High-Reward Research program, honors innovative and unconventional research that has the potential to affect dramatic change in important areas of biomedical research. The program aims to support research that might not be able to secure a traditional NIH R01 grant because of the risks involved, but whose potential to improve lives is tremendous.
Andrews’ research deals with in vivo neurotransmitter monitoring. Her work focuses on anxiety and depression and could improve our understanding of how serotonin systems encode emotionally important information.
“Receiving an NIH Director’s Transformative Award will enable our multi-investigator team to reduce to practice ideas that we have been nurturing and investigating for almost 20 years,” said Andrews. “We aim to design and to fabricate in vivo sensors for a wide range of neurotransmitters including difficult but important targets like GABA and dynorphin. We expect these sensors will revolutionize understanding of how information is encoded in chemical neurotransmission.”
Andrews is a Professor of Psychiatry & Biobehavioral Sciences and Chemistry & Biochemistry at the University of California, Los Angeles. In addition to her work with ACS, Andrews is a member of the American College of Neuropsychopharmacology and the International Society for Serotonin Research President-Elect. She’s also been honored by the NIH several times in the past, as the winner of the NIH Fellows Award for Research Excellence, the NIH Predoctoral Intramural Research Training Award, and the NIH Postdoctoral Intramural Research Training Award.